Xülasə Əsaslar Tərif Epidemiologiya etiologiya Patoziologiya

Qrip infeksiyası

İstinad edilən materiallar

İSTİNAD EDİLƏN MATERİALLAR

11. Stephenson I, Zambon M. The epidemiology of inuenza. Occup Med (Lond). 2002;52:241-247.

Abstrakt

12. Klimov A, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant inuenzae A

viruses by immunodecient patients: detection by polymerase chain reaction-restriction analysis. J

Infect Dis. 1995;172:1352-1355.

 Abstrakt

13. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal

inuenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59:1057-1062. 

 Tam

mətn 

 

 Abstrakt

14. Kostova D, Reed C, Finelli L, et al. Inuenza illness and hospitalizations averted by inuenza

vaccination in the United States, 2005-2011. PLoS One. 2013;8:e66312. 

 Tam mətn 

 

 Abstrakt

15. Centers for Disease Control and Prevention (CDC). Inuenza (u). November 2015. http://

www.cdc.gov (last accessed 9 March 2017). 

 Tam mətn

16. Govaert TM, Thijs CT, Masurel N, et al. The ecacy of inuenza vaccination in elderly individuals: a

randomized double-blind placebo-controlled trial. JAMA. 1994;272:1661-1665.

 Abstrakt

17. Jeerson T, Rivetti D, Rivetti A, et al. Ecacy and eectiveness of inuenza vaccines in elderly

people: a systematic review. Lancet. 2005;366:1165-1174.

 Abstrakt

18. Monto AS, Rottho J, Teich E, et al. Detection and control of outbreaks in well-vaccinated nursing

home populations. Clin Infect Dis. 2004;39:459-464.

 Abstrakt

19. Nichol KL, Nordin JD, Nelson DB, et al. Eectiveness of inuenza vaccine in the community-dwelling

elderly. N Engl J Med. 2007;357:1373-1381. 

 Tam mətn 

 

 Abstrakt

20. Committee on Infectious Diseases. Recommendations for prevention and control of inuenza in

children, 2015-2016. Pediatrics. 2015;136:792-808. 

 Tam mətn 

 

 Abstrakt

21. Hutchinson AF, Ghimire AK, Thompson MA, et al. A community-based, time-matched, case-control

study of respiratory viruses and exacerbations of COPD. Respir Med. 2007;101:2472-2481.

 Abstrakt

22. Nichol KL, Nordin J, Mullooly J, et al. Inuenza vaccination and reduction in hospitalizations for

cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-1332. 

 Tam mətn 

 

Abstrakt

23. Renal Association. Brieng and guidance for adult renal units in the UK during an inuenza

pandemic. August 2009. http://www.renal.org/ (last accessed 9 March 2017). 

 Tam mətn

24. Centers for Disease Control and Prevention (CDC). Guidelines for vaccinating kidney dialysis patients

and patients with chronic kidney disease. December 2012. www.cdc.gov/ (last accessed 9 March

2017). 

 Tam mətn

25. Hak E, Nordin J, Wei F, et al. Inuence of high-risk medical conditions on the eectiveness of

inuenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis.

2002;35:370-377.

 Abstrakt

48

BMJ Qabaqcıl Praktika mövzusunun bu PDF sənədi ən son olaraq yenilənmiş internet variantına əsaslanır: Nov 30, 2017.

BMJ Qabaqcıl Praktika mövzuları müntəzəm olaraq yenilənir və mövzuların ən son variantı

buradan əldə edilə bilər bestpractice.bmj.com .Bu məzmunun istifadəsi bizim qaydalara

müvaqdir İmtina. © © BMJ Publishing Group Ltd 2018. Bütün hüquqlar qorunur.

---

Qrip infeksiyası

İstinad edilən materiallar

26. Orzeck EA, Shi N, Blumentals WA. Oseltamivir and the risk of inuenza-related complications and

hospitalizations in patients with diabetes. Clin Ther. 2007;29:2246-2255.

 Abstrakt

27. Mehta SR, Afenyi-Annan A, Byrns PJ, et al. Opportunities to improve outcomes in sickle cell disease.

Am Fam Physician. 2006;74:303-310.

 Abstrakt

28. Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised

patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human

immunodeciency virus infection. Semin Respir Crit Care Med. 2007;28:222-242.

 Abstrakt

29. Beck CR, McKenzie BC, Hashim AB, et al. Inuenza vaccination for immunocompromised

patients: systematic review and meta-analysis from a public health policy perspective. PLoS One.

2011;6:e29249. 

 Tam mətn 

 

 Abstrakt

30. McKittrick N, Frank I, Jacobson JM, et al. Improved immunogenicity with high-dose seasonal

inuenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann Intern Med.

2013;158:19-26. 

 Tam mətn 

 

 Abstrakt

31. Madhi SA, Cutland CL, Kuwanda L, et al.; Maternal Flu Trial (Matu) Team. Inuenza vaccination

of pregnant women and protection of their infants. N Engl J Med. 2014;371:918-931. 

 Tam mətn 

 

Abstrakt

32. Centers for Disease Control and Prevention (CDC). Recommendations for obstetric health care

providers related to use of antiviral medications in the treatment and prevention of inuenza. October

2016. http://www.cdc.gov/ (last accessed 9 March 2017). 

 Tam mətn

33. Centers for Disease Control and Prevention (CDC). Inuenza vaccination in pregnancy: practices

among obstetrician-gynecologists - United States, 2003-04 inuenza season. MMWR Morb Mortal

Wkly Rep. 2005;54:1050-1052. 

 Tam mətn 

 

 Abstrakt

34. Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention

(CDC). Immunization of health-care personnel: recommendations of the Advisory Committee on

Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1-45. 

 Tam mətn 

 

 Abstrakt

35. Bernstein HH, Starke JR; American Academy of Pediatrics; et al. Policy statement - recommendation

for mandatory inuenza immunization of all health care personnel. Pediatrics. 2010;126:809-815.

Abstrakt

36. Ng AN, Lai CK. Eectiveness of seasonal inuenza vaccination in healthcare workers: a systematic

review. J Hosp Infect. 2011;79:279-286.

 Abstrakt

37. Jackson LA, Gaglani MJ, Keyserling HL, et al. Safety, ecacy, and immunogenicity of an inactivated

inuenza vaccine in healthy adults: a randomized, placebo-controlled trial over two inuenza

seasons. BMC Infect Dis. 2010;10:71.

 Abstrakt

38. Beyer WE, Nauta JJ, Palache AM, et al. Immunogenicity and safety of inactivated inuenza vaccines

in primed populations: a systematic literature review and meta-analysis. Vaccine. 2011;29:5785-5792.

Abstrakt

İSTİNAD EDİLƏN MATERİALLAR

BMJ Qabaqcıl Praktika mövzusunun bu PDF sənədi ən son olaraq yenilənmiş internet variantına əsaslanır: Nov 30, 2017.

BMJ Qabaqcıl Praktika mövzuları müntəzəm olaraq yenilənir və mövzuların ən son variantı

buradan əldə edilə bilər bestpractice.bmj.com .Bu məzmunun istifadəsi bizim qaydalara

müvaqdir İmtina. © © BMJ Publishing Group Ltd 2018. Bütün hüquqlar qorunur.

49

---